title: Characterization of yeasts colonizing in healthy individuals.
abstract: Opportunistic yeast pathogens may switch from harmless commensal to pathogenic relationships with the host under different conditions. They usually cause superficial infections, but may be the agents of more significant infections in immunocompromised patients. To investigate yeast colonization in the oral cavities of clinically healthy individuals, we collected oral swabs from 323 students and staff at the National Health Research Institutes, Taiwan. A total of 49 (15.2%) volunteers were colonized by low levels of yeasts and of these, only 3 (6.1%) were co-colonized by more than one species. Among the 52 isolates, comprising seven fungal genera and 13 species, Candida albicans (57.7%) was the dominant species, followed by Candida parapsilosis (15.4%). There was only one isolate of C. parapsilosis that showed, in vitro, a high (2 μg/ml) minimum inhibitory concentration (MIC) to amphotericin B. There were six (11.5%) isolates with fluconazole MICs ≥ 64 μg/ml and all of them were non-Candida species. With the exception of Cryptococcus albidus, the remaining five isolates had voriconazole MICs ≥ 4 μg/ml. In addition, there was one C. albicans isolate with relatively high fluconazole (32 μg/ml) and voriconazole (4 μg/ml) MICs.
authors.affiliation: Institute of Molecular Medicine and Bioengineering, National Chiao Tung University, Hsinchu, Taiwan.
authors.forename: Y L
authors.initials: YL
authors.lastname: Yang
authors.forename: S N
authors.initials: SN
authors.lastname: Leaw
authors.forename: A H
authors.initials: AH
authors.lastname: Wang
authors.forename: H T
authors.initials: HT
authors.lastname: Chen
authors.forename: W T
authors.initials: WT
authors.lastname: Cheng
authors.forename: H J
authors.initials: HJ
authors.lastname: Lo
mesh_terms: D000293:Adolescent; D000328:Adult; D000666:Amphotericin B / Q000494:pharmacology; D000935:Antifungal Agents / Q000494:pharmacology; D002353:Carrier State / Q000382:microbiology*; D005260:Female; D015725:Fluconazole / Q000494:pharmacology; D006805:Human Experimentation; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009055:Mouth / Q000382:microbiology*; D011743:Pyrimidines / Q000494:pharmacology; D013624:Taiwan; D014230:Triazoles / Q000494:pharmacology; D065819:Voriconazole; D015003:Yeasts / Q000145:classification* / Q000302:isolation & purification*; D055815:Young Adult
chemical_list: D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D000666:Amphotericin B; D015725:Fluconazole; D065819:Voriconazole